Communiqués Certara, Inc.

Actions

CERT

US15687V1098

Logiciels

Marché Fermé - Nasdaq 22:00:00 15/09/2026			Varia. 5j.	Varia. 1 janv.
8,400 ^USD	+5,00%		+5,79%	-4,65%

19/08	Flash résultats (CERT) : Cerrado Gold Inc. publie un chiffre d'affaires de 64,6 millions de dollars au deuxième trimestre, contre une estimation FactSet de 63,1 millions de dollars	MT
04/08	Certara, Inc. annonce des changements au sein de sa direction	CI

Communiqués

04/08	Certara Reports Second Quarter 2026 Financial Results	GL
15/07	Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026	GL
07/07	Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit	GL
07/07	Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit	AQ
17/06	Certara Announces CFO Transition	GL
18/05	Certara to Participate in Upcoming Investor Conferences	GL
11/05	Certara : 1Q26 Earnings Presentation	PU
11/05	Certara Reports First Quarter 2026 Financial Results	GL
08/05	Altasciences et Certara annoncent un partenariat stratégique visant à accélérer le développement de médicaments en phase précoce	BU
07/05	Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development	BU
22/04	Certara : Regulatory and Medical Writing – Supplemental Information	PU
22/04	Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat	GL
09/04	Certara to Report First Quarter 2026 Financial Results on May 11th, 2026	GL
03/03	Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib	GL
27/02	Certara to Participate in Upcoming Investor Conferences	GL
26/02	Certara : Fourth Quarter 2025 Earnings Conference Call	PU
26/02	Certara : 4Q25 Earnings Presentation FINAL	PU
26/02	Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance	GL
26/02	Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance	AQ
29/01	Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025	GL
05/01	The data fragmentation problem holding drug discovery back	AQ
11/12	Certara Appoints Jon Resnick as Chief Executive Officer	GL
06/11	Certara : 3Q25 Earnings Presentation FINAL 11.6.25	PU
06/11	Certara Reports Third Quarter 2025 Financial Results	GL
04/11	Certara Automates Scientific Workflows with Phoenix® Cloud	GL